Ever watched a private company rocket higher the moment it hits the public markets and thought, “I wish I could have gotten exposure a few weeks earlier”? That exact frustration sits at the center of a fresh proposal that landed on regulators’ desks this week. I’ve been following these gray-zone products for a while, and the latest move feels different. Two groups just asked the Securities and Exchange Commission to build a real framework around something they call IPOP contracts — cash-settled perpetual instruments that track companies heading toward an IPO without handing anyone actual shares.
Why Pre IPO Perps Suddenly Matter
The idea is straightforward on paper. An IPOP would give traders pure price exposure to a firm that has already filed registration documents but has not yet started trading. No voting rights. No allocation privileges. No claim against the issuer. Just a continuously priced derivative that settles in cash. The groups behind the letter argue that American investors currently sit on the sidelines while offshore platforms already run these markets.
What caught my attention is the data they brought. Five completed markets on one platform ran between one and twenty-five calendar days before the related listings. Final prices before the open sat within a surprisingly tight band of the eventual opening prints. Four of the U.S. offerings then priced between roughly eleven and thirty-eight percent below the level those contracts showed the day before. That kind of signal is hard to ignore if you care about how IPO books get built.
Still, five examples do not make a market. The letter itself admits as much. It also flags the messy reality that private companies rarely publish continuous, authoritative prices the way listed equities do. Oracle design therefore becomes the make-or-break piece of any workable product.
The Five Regulatory Pillars in Plain Language
Rather than dropping a vague wish list, the submission organizes its request around five clear pillars. I’ve spent time walking through each one because the details matter more than the headlines.
First comes product classification. The groups want the SEC and the Commodity Futures Trading Commission to decide whether equity-linked perpetuals count as security futures or security-based swaps. That single determination would set registration rules, venue requirements, clearing standards, and margin treatment. Without it, everything else stays theoretical.
Second is disclosure. The letter pushes for clear explanations of funding rates, leverage mechanics, liquidation processes, pricing methodology, settlement terms, and any conversion features. Holders should never be treated like equity owners, so the paperwork has to reflect that reality from day one.
Third involves listing eligibility. An IPOP would only be available for a defined window after a company files its registration documents publicly. Oracle sources and settlement procedures would be announced in advance. Any later change would require fresh disclosure. That structure aims to keep the product tightly linked to an actual IPO process rather than turning into open-ended speculation on private names.
Fourth focuses on investor access. A phased rollout is suggested, complete with leverage caps and position limits in the early stages. Retail participation would expand only after the framework proves stable. I’ve seen too many products open the floodgates too early; this cautious approach feels more realistic.
Fifth and final is market integrity. Audit trails, conflict-of-interest controls, and restrictions on deployers or affiliates trading while holding material nonpublic information sit at the core. Without those guardrails, the entire experiment collapses under the first scandal.
What the Early Markets Actually Showed
Numbers tell a cleaner story than theory. The five completed contracts covered names that later listed or prepared to list. Contract life ranged from a single day to just over three weeks. Final marks before the open landed between 0.44 percent and 7.23 percent of the eventual stock opening price. That is not perfect, but it is tighter than many traditional pre-IPO secondary prints I’ve watched over the years.
Four of the U.S. deals then came to market at discounts ranging from about eleven percent to thirty-eight percent versus the IPOP level recorded one day earlier. The groups present this as evidence that continuously traded derivatives can give issuers and underwriters an independent read on demand. Fair enough. Yet a five-name sample remains too thin to claim consistent improvement across every IPO. Market conditions, sector, and size all shift the outcome.
One case also exposed a practical headache. A single low-volume share trade fed into an oracle and shoved the mark price of one contract down roughly eighteen percent in a short window. Liquidations followed. The platform later covered eligible losses on a discretionary basis and insisted its oracle behaved exactly as designed. The episode still underlines a core truth: a technically correct process can produce a price that does not reflect deep, durable interest.
Continuously traded derivatives could provide issuers and underwriters with an independent measure of demand.
That sentence from the letter captures the upside. The SK Hynix-style glitch captures the downside. Both belong in any honest discussion.
Oracle Design Is the Real Bottleneck
Private companies do not publish continuous market prices the way listed stocks do. Any pre-IPO perpetual therefore lives or dies by the rules its deployer writes for the oracle. Those rules must be public, testable, and resistant to thin or manipulated inputs.
I’ve found that most of the risk concentrates in three places. First, source selection. Second, weighting and outlier filters. Third, what happens when the only available print is a one-share trade in a sleepy session. The letter calls for disclosed oracle rules and market controls precisely because those three areas can generate large, sudden mark moves that feel disconnected from economic reality.
A well-designed oracle will not eliminate every anomaly. It can, however, make the process transparent enough that participants understand the risks before they post margin. That transparency is non-negotiable if regulators ever green-light broader access.
Classification Will Decide Everything Else
Right now the products sit offshore and exclude U.S. persons. No approved domestic framework exists. The CFTC has already signaled that equity-based perpetuals outside a narrow set of approvals would benefit from coordinated review with the SEC. Both agencies have also asked whether a cash-settled perpetual referencing an equity security could qualify as a security future even when the underlying shares have not yet begun trading.
The answer to that question will determine whether existing security-futures rules can stretch to cover a pre-listing instrument or whether entirely new guidance is required. No deadline attaches to the current submission. Staff discussions, additional comment requests, joint guidance, or formal rulemaking all remain possible next steps. The letter simply puts a concrete proposal on the public record.
In my view, the classification fight is the single largest gating item. Everything else — disclosure templates, listing windows, leverage limits — can be refined once the product type is settled. Until then, the conversation stays theoretical for American retail accounts.
Price Discovery Versus Investor Protection
Supporters emphasize the price-discovery benefit. A continuous market that runs in the weeks before an IPO can surface demand that traditional roadshows sometimes miss. Issuers and underwriters might use that information to set a more accurate range. Investors locked out of private rounds could gain limited, cash-settled exposure without needing special access.
Critics focus on protection. Pre-IPO names lack the continuous pricing, research coverage, and disclosure cadence of public companies. Leverage and liquidations can amplify losses when the oracle is thin. Affiliates or deployers holding material nonpublic information create classic conflict risks. A phased rollout with hard position limits is one way to balance those tensions, but it is not a complete answer.
Perhaps the most interesting tension sits in the middle. The same product that improves price discovery can also create new avenues for speculation that has little connection to fundamentals. Designing rules that preserve the useful signal while dampening pure gambling is harder than it looks on a whiteboard.
What a Practical Framework Might Look Like
If regulators decide to move, several concrete elements would need to appear early. Clear product definitions that distinguish IPOP contracts from both traditional futures and equity swaps. Standardized disclosure packages covering funding, leverage, liquidation, and oracle mechanics. Listing eligibility tied tightly to public registration filings. Pre-announced settlement and conversion rules. Audit-trail requirements and trading restrictions for insiders. And a staged expansion of retail access that begins with strict leverage and position caps.
None of those pieces requires reinventing the entire derivatives rulebook. Many already exist in related markets. The challenge is adapting them to an instrument whose underlying shares have not yet opened for trading. That adaptation is where most of the policy work will sit.
- Product classification must come first
- Oracle rules need public, testable standards
- Listing windows should stay short and linked to filings
- Retail access works best in phases with hard limits
- Market-integrity controls cannot be optional
Those five points map almost one-to-one onto the pillars the letter proposes. Implementation details will still take months of staff work even if the broad direction is accepted.
Risks That Remain Even With Perfect Rules
A well-written framework does not eliminate every hazard. Thin liquidity in the early days of a contract can still produce large mark swings from a single trade. Funding rates can turn expensive when demand is one-sided. Liquidations cascade when volatility spikes. And the absence of an actual share means the product never becomes a claim on the company itself — a fact some retail participants may overlook until losses arrive.
I’ve watched enough leveraged products to know that education often lags innovation. Clear disclosure helps, but it does not guarantee understanding. Position limits and leverage caps are blunt tools, yet they remain among the most effective ones available while the market is still young.
Another quiet risk is regulatory fragmentation. If the SEC and CFTC land on different classifications or timelines, platforms will face conflicting requirements. Coordinated review is the only practical path that keeps the product coherent.
How This Fits Into Broader Market Modernization
IPO processes have drawn criticism for years. Pricing gaps between private secondary markets and the eventual public open are common. Roadshows still rely heavily on anecdotal demand signals. A continuous, transparent derivative market that runs in the final weeks before listing could, in theory, add one more data point. Whether that data point improves outcomes for issuers, underwriters, or public buyers is an empirical question that only larger sample sizes can answer.
The current letter does not claim to solve every IPO friction. It simply argues that the price signal already visible in a handful of offshore markets is worth formalizing under clear U.S. rules. That modest framing is more persuasive than sweeping promises of transformation.
In practice, any approved framework would likely start narrow. Only companies that have filed registration documents. Only contracts with fully disclosed oracles. Only participants who meet certain sophistication or margin thresholds at the outset. Expansion would follow demonstrated stability. That sequence matches how other novel derivatives have entered regulated markets over the past decade.
Looking Ahead Without the Hype
No one should treat the submission as an imminent product launch. Posting a letter to a public docket confirms receipt. It does not signal endorsement. Staff may request more data, open a formal comment period, or simply take no further action. The absence of a response deadline means the timeline remains open-ended.
What the letter does achieve is a clearer public record of the issues. Classification, disclosure, eligibility, access, and integrity now sit in one place with concrete recommendations attached. Future discussions can reference those recommendations rather than starting from zero.
For traders who have watched pre-IPO names gap higher on the open, the appeal is obvious. For regulators charged with investor protection, the risks are equally clear. Bridging those two perspectives will require patient, technical work rather than slogans. The five pillars offer a starting map. Whether the agencies decide to follow it is a decision still months, and possibly years, away.
In the meantime, the offshore markets continue to operate for non-U.S. participants. The price signals they generate remain available for anyone who wants to study them. Those signals are imperfect, limited in sample size, and subject to oracle quirks. They are also the most concrete evidence currently on the table that continuous pre-IPO pricing can exist. That evidence is now part of the official conversation. How far the conversation travels from here depends on the next set of staff memos and policy choices.
The core tension will not disappear. Price discovery and investor protection pull in different directions more often than they align. Any workable regime will need to acknowledge both forces instead of pretending one can be optimized away. The letter at least frames the problem honestly. That alone makes it worth reading carefully rather than dismissing as another speculative pitch.
Practical Takeaways for Anyone Watching the Space
If you follow derivatives markets, keep an eye on three developments. First, any joint statement or staff guidance from the two agencies on equity-linked perpetuals. Second, additional comment letters that either support or challenge the five-pillar structure. Third, changes in how existing offshore platforms handle oracle transparency and loss events. Those three threads will reveal whether the idea is gaining traction or quietly fading.
For issuers and underwriters, the early data is worth noting even if the products stay offshore for now. A market that runs in the final weeks before listing can surface demand information that traditional processes sometimes miss. Whether that information improves pricing remains an open empirical question, but ignoring it entirely feels shortsighted.
Retail participants should treat any future approved product with the same caution applied to other leveraged instruments. Cash settlement removes share ownership, yet it does not remove the possibility of rapid losses. Position limits and leverage caps exist for a reason. Understanding the oracle rules before posting margin is not optional homework; it is the difference between informed risk and avoidable surprise.
I’ve found that the most useful attitude toward novel market structures is curiosity paired with skepticism. The pre-IPO perpetual idea is clever. The early results are intriguing. The regulatory path is still long and uncertain. Holding those three facts at the same time is more productive than either uncritical enthusiasm or reflexive dismissal.
The letter itself runs fifteen pages. Most of the substance sits in the detailed recommendations rather than the high-level summary. Anyone serious about the topic should read the full document rather than relying on secondary accounts. The specific language around oracle disclosure, listing windows, and phased access contains the real policy content.
Ultimately, the question is not whether pre-IPO price signals can exist. A handful of markets have already demonstrated that they can. The question is whether those signals can be brought under a coherent U.S. regulatory framework that protects participants without extinguishing the information value. The five pillars attempt to answer that question. The agencies will decide how much of the answer they want to adopt.
Until then, the gray zone continues. Offshore platforms keep running the products for eligible users. Domestic accounts remain excluded. And the price gaps between private secondary markets and the eventual public open keep appearing with each new listing cycle. Whether a formal IPOP market can shrink those gaps is the experiment that has not yet been run at scale. The proposal now on the table is simply the first detailed invitation to begin designing that experiment under clear rules.
That invitation is worth taking seriously. Not because every detail is perfect, but because the underlying problem — limited, opaque price discovery in the final stretch before an IPO — is real. Addressing it with carefully designed derivatives is one possible path. Whether it becomes the preferred path depends on the technical work that still lies ahead.
For now, the conversation has moved from pure speculation into a structured regulatory request. That shift alone changes the tone. Future discussions can reference concrete pillars rather than abstract possibilities. And that, more than any single data point from the five early markets, may prove the most lasting contribution of the letter.
